Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

The Spanish Association with Osteoporosis and Osteoarthritis (AECOSAR) and the Osteoarthritis Foundation International (OAFI) ...

The U.S. Food and Drug Administration (FDA) has granted andecaliximab a Rare Pediatric Disease Designation (RPDD) for the treatment of FOP. An RPDD designation is granted to potential treatments for ...

The global bone growth products market size was valued at USD 1.29 billion in 2024 and is projected to reach from USD 1.34 ...

‘The message I want to convey is that by investing in research, health and education we can improve people’s lives. Eric ...

Hence, they can only attain a certain height no matter how much they try. However, it is often said that some foods can help ...

Bone loss resulting from trauma, fractures, or disease presents a major global health challenge, often leading to long-term ...

Bone regeneration research has taken a significant leap forward with the discovery of a crucial mechanism that could transform treatments for bone ...

Bone regeneration research has taken a significant leap forward with the discovery of a crucial mechanism that could ...

Bone marrow stimulation techniques such as microfracture are primarily used to treat focal chondral defects; the evidence for the use of these techniques for knee OA remains unclear. The goal of ...

The paper presents a streamlined new approach for functional validation of genes known to underlie fragile bone disorders in a relatively high throughput, using CRISPR-mediated knockouts and a number ...